SP-MHCI-0708-3

Human CEACAM5 571-579, CGIQNSVSA

US$507.00

In stock

Description

About Human CEACAM5 571-579, CGIQNSVSA

The Human Carcinoembryonic antigen-related cell adhesion molecule 5 Peptide (IEDB: 157128) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Carcinoembryonic antigen-related cell adhesion molecule 5 Peptide, H-CGIQNSVSA-OH (Uniprot: P06731 aa: 571-579) from JPT is produced under strict quality control and quality management.

Human CEACAM5 571-579, CGIQNSVSA - Specifications

  • Peptide sequence: H-CGIQNSVSA-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Cancer
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human CEACAM5 571-579, CGIQNSVSA

References:
Read References with JPT’s Antigen Peptides
Human CEACAM5 571-579, CGIQNSVSA has been described in:
Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100., Cancer Res, 2009 (PMID: 19789338)
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19., PLoS Pathog, 2021 (PMID: 34529740)

Documentation

Documentation for Human CEACAM5 571-579, CGIQNSVSA

Properties

Properties of Human CEACAM5 571-579, CGIQNSVSA

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Cancer
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human CEACAM5 571-579, CGIQNSVSA

Information Values
Sequence: H-CGIQNSVSA-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote